Clinical Trials on Hydroxychloroquine in Finland

Total 1 results

Helsinki University Central Hospital
Finnish Cultural Foundation; Orion Corporation, Orion Pharma; Finnish Foundation... and other collaborators

Completed

Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial (OXI)

Myocardial Infarction | Cardiovascular Diseases | Inflammation | Acute Coronary Syndrome | Hydroxychloroquine | Antirheumatic Agents

Finland

3

Subscribe